サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1605903

血糖値モニタリング装置市場、規模、シェア、動向、産業分析レポート：製品別、最終用途別、地域別 - 市場予測 2025年～2034年

Blood Glucose Monitoring Device Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034

出版日
ページ情報
英文 120 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
血糖値モニタリング装置市場、規模、シェア、動向、産業分析レポート：製品別、最終用途別、地域別 - 市場予測 2025年～2034年
出版日: 2024年11月01日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、血糖値モニタリング装置市場規模は2034年までに313億1,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

血糖値モニタリング装置市場は、糖尿病患者にとって重要な血糖値を測定・管理するために設計された技術を包含しています。不健康なライフスタイル、人口の高齢化、遺伝的要因によって糖尿病の世界の有病率が上昇しているため、効果的な血糖管理ソリューションに対する需要が大幅に増加しています。血糖値モニタリングの重要性に対する認識が高まり続ける中、患者もヘルスケアプロバイダーも糖尿病ケアを強化するためにこれらの技術を進歩させています。

技術の進歩は、血糖値モニタリング装置市場の成長において重要な役割を果たしています。非侵襲的なグルコースモニタリング、センサー精度の向上、最新デバイスの強化された接続機能などの技術革新は、血糖モニタリングをより効率的でユーザーフレンドリーなものにしています。これらの進歩は、より良い疾患管理と患者転帰の改善に寄与し、需要増加を促進しています。

例えば、2023年7月、Dexcom, Inc.は、カナダ保健省の認証を受けた次世代Dexcom G7 Continuous Glucose Monitoring Systemを発売しました。このシステムは2歳以上の糖尿病患者向けに設計されています。

ウェアラブル機器やスマート・グルコース・モニターの採用が増加しており、リアルタイムの追跡やシームレスなデータ統合が成長の原動力となっています。新興市場におけるヘルスケア支出の増加と相まって、在宅検査へのシフトがこの動向をさらに後押ししています。ユーザーフレンドリーで正確、かつ手頃な価格のソリューションを優先し、戦略的パートナーシップや世界市場の拡大を図る企業は、この成長動向を活用するのに有利な立場にあります。

血糖値モニタリング装置市場レポートハイライト

製品別では、自己血糖測定装置分野が2024年の市場を独占しました。これは主に、消費者意識の高まり、在宅検査の利便性、糖尿病有病率の上昇によるものです。

病院・診療所セグメントは、糖尿病患者数の増加、入院患者数の増加、技術の進歩、より良い患者管理のための継続的グルコースモニタリングの重視の高まりにより、最も速いCAGRを記録すると予想されます。

北米は、米国やカナダのような国々における糖尿病有病率の高さや高度なヘルスケアインフラなどの要因により、2024年の市場を独占しました。

アジア太平洋地域は、都市化の進展とライフスタイルの変化が糖尿病罹患率の上昇に寄与している中国やインドなどの国々における糖尿病罹患率の上昇により、最も速いCAGRを記録すると予想されます。

主な市場企業には、Abbott Laboratories; Acon Laboratories Inc.; ARKRAY Inc.; Bayer AG; Becton, Dexcom, Inc.; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Johnson & Johnson; Novo Nordisk A/S; Sanofi; Terumo Corporation; Ypsomed.などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の血糖値モニタリング装置市場の洞察

  • 市場スナップショット
  • 血糖値モニタリング装置市場力学
    • 促進要因と機会
      • 高度な血糖値モニタリング装置の増加
      • 高齢化人口の増加
    • 抑制要因と課題
      • 代替品の入手可能性と高コスト
  • PESTEL分析
  • 血糖値モニタリング装置の市場動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の血糖値モニタリング装置市場：製品別

  • 主な調査結果
  • イントロダクション
  • 自己監視デバイス
  • 持続血糖測定装置

第6章 世界の血糖値モニタリング装置市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院・クリニック
  • 診断センター
  • ホームケア設定

第7章 世界の血糖値モニタリング装置市場：地域別

  • 主な調査結果
  • イントロダクション
    • 血糖値モニタリング装置市場評価：地域、2020～2034年
  • 北米
    • 北米：製品別、2020～2034年
    • 北米：最終用途別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別、2020～2034年
    • 欧州：最終用途別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：製品別、2020～2034年
    • アジア太平洋地域：最終用途別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：製品別、2020～2034年
    • 中東・アフリカ：最終用途別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別、2020～2034年
    • ラテンアメリカ：最終用途別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • ARKRAY Inc.
  • Bayer AG
  • BD
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Medtronic Plc
  • Novo Nordisk A/S
  • Sanofi
  • Terumo Corporation
  • Ypsomed
図表

List of Tables:

  • Table 1 Global Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 3 North America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 4 North America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 U.S.: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 6 U.S.: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 Canada: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 8 Canada: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 Europe: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 10 Europe: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 11 UK: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 12 UK: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 France: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 14 France: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 15 Germany: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 16 Germany: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Italy: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Italy: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 Spain: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 20 Spain: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 23 Russia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 24 Russia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 China: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 30 China: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 India: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 32 India: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 35 Japan: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 36 Japan: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 39 South Korea: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 40 South Korea: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Australia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Australia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 UAE: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 50 UAE: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 51 Israel: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 52 Israel: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 South Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 54 South Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 Latin America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 58 Latin America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 59 Mexico: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 60 Mexico: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Brazil: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Brazil: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 63 Argentina: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 64 Argentina: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • List of Figures:
  • Figure 1. Global Blood Glucose Monitoring Device Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Blood Glucose Monitoring Device Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Blood Glucose Monitoring Device Market, by End Use, 2024 & 2034 (USD Billion)
目次
Product Code: PM1564

The blood glucose monitoring devices market size is expected to reach USD 31.31 billion by 2034, according to a new study by Polaris Market Research. The report "Blood Glucose Monitoring Devices Market Size, Share, Trends, Industry Analysis Report: By Product, End-Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blood glucose monitoring devices market encompasses technologies designed to measure and manage blood glucose levels, which are crucial for diabetic patients. The rising global prevalence of diabetes, driven by unhealthy lifestyles, aging populations, and genetic factors, has significantly increased the demand for effective glucose management solutions. As awareness of the importance of monitoring blood glucose levels continues to grow, both patients and healthcare providers are advancing these technologies to enhance diabetes care.

Technological advancements are playing a crucial role in the growth of the blood glucose monitoring devices market. Innovations such as non-invasive glucose monitoring, improved sensor accuracy, and enhanced connectivity features in modern devices are making blood glucose monitoring more efficient and user-friendly. These advancements contribute to better disease management and improved patient outcomes, driving increased demand.

For instance, in July 2023, Dexcom, Inc. launched the next-generation Dexcom G7 Continuous Glucose Monitoring System, certified by Health Canada. This system is designed for individuals with diabetes aged two years and older.

The increasing adoption of wearable devices and smart glucose monitors is driving growth in real-time tracking and seamless data integration. The shift toward home-based testing, coupled with rising healthcare spending in emerging markets, further supports this trend. Companies that prioritize user-friendly, accurate, and affordable solutions, along with strategic partnerships and global market expansion, are well-positioned to capitalize on this growing trend.

Blood Glucose Monitoring Devices Market Report Highlights

By product outlook, the self-monitoring devices segment dominated the market in 2024, mainly due to increasing consumer awareness, the convenience of home testing, and the rising prevalence of diabetes.

The hospitals & clinics segment is expected to register the fastest CAGR due to the growing number of diabetic patients, increasing hospital admissions, advancements in technology, and a rising emphasis on continuous glucose monitoring for better patient management.

North America dominated the market in 2024 due to factors such as the high prevalence of diabetes and advanced healthcare infrastructure in countries like the United States and Canada.

Asia Pacific is expected to register the fastest CAGR, owing to the rising prevalence of diabetes in countries such as China and India, where increasing urbanization and lifestyle changes contribute to higher diabetes rates.

The key market players include Abbott Laboratories; Acon Laboratories Inc.; ARKRAY Inc.; Bayer AG; Becton, Dexcom, Inc.; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Johnson & Johnson; Novo Nordisk A/S; Sanofi; Terumo Corporation; Ypsomed.

Polaris Market Research has segmented the blood glucose monitoring devices market report based on product, end-use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

  • Self-monitoring Devices
  • Blood Glucose Meter
  • Testing Strips
  • Lancets
  • Continuous Blood Glucose Monitoring Devices
  • Sensors
  • Transmitter & Receiver
  • Insulin Pumps

By End-Use Outlook (Revenue-USD Billion, 2020-2034)

  • Hospitals & Clinics
  • Diagnostic Centers
  • Home Care Settings

By Regional Outlook (Revenue-USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of the Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Blood Glucose Monitoring Device Market Insights

  • 4.1. Blood Glucose Monitoring Device Market - Market Snapshot
  • 4.2. Blood Glucose Monitoring Device Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in Advanced Blood Glucose Monitoring Devices
      • 4.2.1.2. Increasing Aging Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Availability of substitutes and high cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Blood Glucose Monitoring Device Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Blood Glucose Monitoring Device Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Self-Monitoring Devices
    • 5.3.1. Global Blood Glucose Monitoring Device Market, by Self-Monitoring Devices, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Blood Glucose Meter
      • 5.3.2.1. Global Blood Glucose Monitoring Device Market, by Blood Glucose Meter, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Testing Strips
      • 5.3.3.1. Global Blood Glucose Monitoring Device Market, by Testing Strips, by Region, 2020-2034 (USD Billion)
    • 5.3.4. Lancets
    • 5.3.5. Global Blood Glucose Monitoring Device Market, by Lancets, by Region, 2020-2034 (USD Billion)
  • 5.4. Continuous Blood Glucose Monitoring Devices
    • 5.4.1. Global Blood Glucose Monitoring Device Market, by Continuous Blood Glucose Monitoring Devices, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Sensors
    • 5.4.3. Global Blood Glucose Monitoring Device Market, by Sensors, by Region, 2020-2034 (USD Billion)
    • 5.4.4. Transmitter & Receiver
    • 5.4.5. Global Blood Glucose Monitoring Device Market, by Transmitter & Receiver, by Region, 2020-2034 (USD Billion)
    • 5.4.6. Insulin Pumps
    • 5.4.7. Global Blood Glucose Monitoring Device Market, by Insulin Pumps, by Region, 2020-2034 (USD Billion)

6. Global Blood Glucose Monitoring Device Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • 6.3. Hospitals & Clinics
    • 6.3.1. Global Blood Glucose Monitoring Device Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
  • 6.4. Diagnostic Centers
    • 6.4.1. Global Blood Glucose Monitoring Device Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
  • 6.5. Home Care Settings
    • 6.5.1. Global Blood Glucose Monitoring Device Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)

7. Global Blood Glucose Monitoring Device Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Blood Glucose Monitoring Device Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Blood Glucose Monitoring Device Market - North America
    • 7.3.1. North America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
    • 7.3.2. North America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.3. Blood Glucose Monitoring Device Market - U.S.
      • 7.3.3.1. U.S.: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.4. Blood Glucose Monitoring Device Market - Canada
      • 7.3.4.1. Canada: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • 7.4. Blood Glucose Monitoring Device Market - Europe
    • 7.4.1. Europe: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.3. Blood Glucose Monitoring Device Market - UK
      • 7.4.3.1. UK: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.4. Blood Glucose Monitoring Device Market - France
      • 7.4.4.1. France: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.5. Blood Glucose Monitoring Device Market - Germany
      • 7.4.5.1. Germany: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.6. Blood Glucose Monitoring Device Market - Italy
      • 7.4.6.1. Italy: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.7. Blood Glucose Monitoring Device Market - Spain
      • 7.4.7.1. Spain: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.8. Blood Glucose Monitoring Device Market - Netherlands
      • 7.4.8.1. Netherlands: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.9. Blood Glucose Monitoring Device Market - Russia
      • 7.4.9.1. Russia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.10. Blood Glucose Monitoring Device Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • 7.5. Blood Glucose Monitoring Device Market - Asia Pacific
    • 7.5.1. Asia Pacific: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.3. Blood Glucose Monitoring Device Market - China
      • 7.5.3.1. China: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.4. Blood Glucose Monitoring Device Market - India
      • 7.5.4.1. India: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.5. Blood Glucose Monitoring Device Market - Malaysia
      • 7.5.5.1. Malaysia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.6. Blood Glucose Monitoring Device Market - Japan
      • 7.5.6.1. Japan: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.7. Blood Glucose Monitoring Device Market - Indonesia
      • 7.5.7.1. Indonesia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.8. Blood Glucose Monitoring Device Market - South Korea
      • 7.5.8.1. South Korea: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.9. Blood Glucose Monitoring Device Market - Australia
      • 7.5.9.1. Australia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.10. Blood Glucose Monitoring Device Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • 7.6. Blood Glucose Monitoring Device Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.3. Blood Glucose Monitoring Device Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.4. Blood Glucose Monitoring Device Market - UAE
      • 7.6.4.1. UAE: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.5. Blood Glucose Monitoring Device Market - Israel
      • 7.6.5.1. Israel: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.6. Blood Glucose Monitoring Device Market - South Africa
      • 7.6.6.1. South Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.7. Blood Glucose Monitoring Device Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
  • 7.7. Blood Glucose Monitoring Device Market - Latin America
    • 7.7.1. Latin America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.3. Blood Glucose Monitoring Device Market - Mexico
      • 7.7.3.1. Mexico: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.4. Blood Glucose Monitoring Device Market - Brazil
      • 7.7.4.1. Brazil: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.5. Blood Glucose Monitoring Device Market - Argentina
      • 7.7.5.1. Argentina: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.6. Blood Glucose Monitoring Device Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Acon Laboratories, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. ARKRAY Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bayer AG
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. BD
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Dexcom, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. F. Hoffmann-La Roche Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Johnson & Johnson
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Medtronic Plc
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Novo Nordisk A/S
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Sanofi
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Terumo Corporation
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Ypsomed
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development